About Nanjing Jiangning Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Nanjing First Hospital, Nanjing Medical University
5
Bayer
2
Eli Lilly and Company
2
B. Braun Medical International Trading Company Ltd.
1
Beijing Tiantan Hospital
1
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
1
Daiichi Sankyo, Inc.
1
GE Healthcare
1
Guangdong Raynovent Biotech Co., Ltd
1
Jinling Hospital, China
1
Mylan Pharma UK Ltd.
1
Clinical Trials at Nanjing Jiangning Hospital
During the past decade, Nanjing Jiangning Hospital conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 2 clinical trials were completed, i.e. on
average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 2 clinical trials were completed. i.e. 20%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Basal Insulin Analog and Insulin Analog Mid Mixture in Chinese Participants With Type 2 Diabetes Mellitus
2017-02-06
2019-07-12
Completed
814
Comparison of Efficacy and Safety of Prandilin and NovoRapid in Newly Diagnosed Type 2 Diabetes
2015-02-01
2016-07-01
Completed
110
A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 2 Diabetes Mellitus
2018-03-22
2020-03-18
Completed
536
The Blood Glucose Control in Patients With Type 2 Diabetes Treated With Glargine
2018-06-12
2019-07-31
Unknown status
100
Effects of Replacing Lantus With Basalin on the Glycemic Variation in Patients With Type 2 Diabetes Mellitus
2018-08-15
2019-07-30
Unknown status
100
Post-Marketing Safety Study in ST-Segment Elevation Myocardial Infarction (STEMI) Participants Undergoing Primary Percutaneous Coronary Intervention (PCI) Procedure With VISIPAQUE® as the Contrast Medium
2018-11-05
2021-06-07
Completed
2,755
Effect of FGM on Glucose Control in Diabetic Patients
2018-12-20
2019-12-31
Unknown status
600
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Nanjing Jiangning Hospital" #1 sponsor was "Nanjing First Hospital, Nanjing Medical University" with 5 trials, followed by "Bayer" with 2 trials
sponsored, "Eli Lilly and Company" with 2 trials sponsored, "B. Braun Medical International Trading Company Ltd." with 1 trials sponsored and "Beijing Tiantan Hospital"
with 1 trials sponsored. Other sponsors include 3 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Nanjing Jiangning Hospital"
#1 collaborator was "Bayer" with 1 trials as a collaborator, "CCRF Inc., Beijing, China" with 1 trials as a collaborator, "Daiichi Sankyo (China) Holdings Co., Ltd." with 1 trials as a collaborator and "Ministry of Science and Technology of the People´s Republic of China" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Nanjing Jiangning Hospital
According to Clinical.Site data, the most researched conditions in "Nanjing Jiangning Hospital" are
"Coronary Artery Disease" (2 trials), "Type 2 Diabetes" (2 trials), "Type 2 Diabetes Mellitus (T2DM)" (2 trials), "Type2 Diabetes" (2 trials) and "Acute Coronary Syndrome" (1 trials). Many other conditions were trialed in "Nanjing Jiangning Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Nanjing Jiangning Hospital
Most popular intervention types in "Nanjing Jiangning Hospital" are "Drug" (15 trials), "Device" (2 trials), "Other" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Acarbose" (1 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials) and "Asundexian (BAY2433334)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Nanjing Jiangning Hospital
The vast majority of trials in "Nanjing Jiangning Hospital" are
18 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Nanjing Jiangning Hospital
Currently, there are NaN active trials in "Nanjing Jiangning Hospital".
1 are not yet recruiting,
5 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Nanjing Jiangning Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Nanjing Jiangning Hospital, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 5 trials, and there were
also 3 trials that are defined as “Not Applicable".